Ligand Pharmaceuticals Incorporated (LGND) — Long-term Investment Intensity
Ligand Pharmaceuticals Incorporated (LGND) has a Long-term Investment Intensity of 23.4% as of December 2025. Long-term investments of $364.83 Million represent 23.4% of total assets of $1.56 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how aggressively does Ligand Pharmaceuticals Incorporated reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Ligand Pharmaceuticals Incorporated Long-term Investment Intensity (2012–2025)
This chart shows how Ligand Pharmaceuticals Incorporated's Long-term Investment Intensity has evolved across 9 annual periods from 2012 to 2025. As of December 2025, the intensity stands at 23.4%, reflecting long-term investments of $364.83 Million against total assets of $1.56 Billion USD. Explore Ligand Pharmaceuticals Incorporated (LGND) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Ligand Pharmaceuticals Incorporated (2012–2025)
The table below presents the year-by-year Long-term Investment Intensity for Ligand Pharmaceuticals Incorporated from 2012 to 2025, covering 9 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Ligand Pharmaceuticals Incorporated market cap and net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 23.4% | $364.83 Million | $1.56 Billion | ▲ +2.6 pp |
| 2024 | 20.8% | $195.93 Million | $941.77 Million | ▲ +14.7 pp |
| 2023 | 6.1% | $48.32 Million | $787.22 Million | ▲ +5.7 pp |
| 2022 | 0.4% | $3.00 Million | $762.67 Million | ▼ -0.6 pp |
| 2017 | 1.0% | $6.44 Million | $671.02 Million | ▼ -0.4 pp |
| 2016 | 1.4% | $8.35 Million | $601.59 Million | ▼ -4.2 pp |
| 2015 | 5.6% | $29.73 Million | $533.93 Million | ▲ +2.7 pp |
| 2014 | 2.9% | $7.42 Million | $258.03 Million | ▼ -5.0 pp |
| 2012 | 7.9% | $8.21 Million | $104.26 Million | — |